Chimeric Therapeutics Limited - Australian Company Profile

What does Chimeric Therapeutics Limited do?

Chimeric Therapeutics is a Public Company that generates the majority of its income from the Scientific Research Services industry.

In 2024 the company generated total revenue of $8,891,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive Officer of Chimeric Therapeutics is either not applicable or not available.The Chairman of Chimeric Therapeutics is Mr Paul Hopper whose official title is Executive Chairman and Founder.

Chimeric Therapeutics Limited is an ASX-listed public company in the biotechnology industry. The Company produces and develops CAR-T technology, aimed to treat tumours. The two main technologies that the Company has developed, are: NK Cell-Derived Allogeneic Therapies (natural detection for the direct kill of cancer cells) T Cell-Derived Autologous Therapies (attack and target antigens, with proven efficacy in blood cancers)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Chimeric Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Chimeric Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Chimeric Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Chimeric Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Chimeric Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Chimeric Therapeutics Limited operates in.

Major Shareholders

We outline the ultimate parent and largest shareholders of Chimeric Therapeutics Limited.

Subsidiaries

View a list of Chimeric Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Chimeric Therapeutics Limited, including founding information, past announcements, mergers and major projects.